Puraply/Affinity/NuTech: payments to doctors
Payments that named Puraply/Affinity/NuTech as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.9M
- Providers
- 1,431
- Transactions
- 4,588
- Average per transaction
- $405
The per-transaction average — $405 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,431 providers the average total is $1,299, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Organogenesis Inc. | $1,858,791 | 100.0% |